<DOC>
	<DOCNO>NCT02486653</DOCNO>
	<brief_summary>The purpose study determine tamsulosin ( `` FLOMAX '' ) effective prevent post-operative urinary retention follow abdominal surgery . Post-operative urinary retention common post-operative complication , occur 30 % patient undergoing abdominal surgery . It describe inability initiate urination properly empty one 's bladder follow surgery . It usually self-limited , require use catheterization empty bladder order prevent injury bladder kidney relief discomfort full bladder . Tamsulosin medication commonly use men urinary symptom relate enlarged prostate . There evidence suggest may also potentially beneficial prevent post-operative urinary retention . Therefore , research study , subject schedule abdominal surgery randomly assign take either tamsulosin once-daily placebo once-daily one week lead surgery , several day surgery . Urinary function assess compare two treatment . The hypothesis tamsulosin reduce rate postoperative urinary retention compare placebo .</brief_summary>
	<brief_title>Prevention Post-operative Urinary Retention</brief_title>
	<detailed_description>Postoperative urinary retention ( POUR ) complicate 30 % general abdominal operation . It result patient discomfort , embarrassment , interference therapy , significant nursing burden . More importantly , urinary retention necessitates use intermittent catheterization placement indwell urinary catheter , expose patient increase risk urinary tract infection ( UTI ) , urethral injury , potentially increased hospital length stay cost . For reason , safe effective intervention prevent POUR would highly valuable . Despite need , contemporary study exist evaluate medication use prevent POUR broad general surgery population . To address gap , investigator design prospective , randomize , double-blind , placebo-controlled trial test hypothesis preoperative loading tamsulosin prevent POUR patient undergo elective , inpatient complex intra-abdominal surgery thereby lead improve short-term outcome . Tamsulosin safe widely-used selective alpha-1-A adrenergic blocker commonly use treatment low urinary tract symptom men benign prostatic hypertrophy . It also show benefit reduce POUR need catheterization men undergo inguinal hernia repair outpatient urologic procedure . This study randomize , double-blind , placebo-controlled trial patient scheduled inpatient complex intra-abdominal surgery randomize receive either tamsulosin placebo 7 day pre-operatively , several day post-operatively , rate POUR compare two group ( Aim 1 ) . A retrospective analysis data use identify risk factor POUR subgroup patient would derive great benefit preoperative tamsulosin ( Aim 2 ) . Furthermore , short-term outcome , include rate urinary tract infection ( UTI ) hospital length stay , compare tamsulosin placebo group ( Aim 3 ) . Enrolled subject randomize use block , stratified randomization process either tamsulosin placebo . Stratification variable include gender , pelvic v non-pelvic surgery , International Prostate Symptom Score ( IPSS ) survey result ( measure baseline low urinary tract symptom ) . After 7-day treatment period , subject undergo surgery schedule , assign treatment continue total 14 day subject either return normal void function , require replacement indwell urinary catheter , discharge hospital .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Urinary Retention</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Englishspeaking Able provide inform consent Scheduled undergo elective , complex intraabdominal operation plan postoperative inpatient stay least 1 night Less age 18 Allergy contraindication tamsulosin Serious sulfa allergy Current use alpha blocker ( alfuzosin , doxazosin , prazosin , silodosin , terazosin , verapamil , tamsulosin ) oral alpha agonist ( midodrine ) , initiation one medication intervention phase study result subject withdrawal study Current warfarin use Preexisting indwell urinary catheter , suprapubic catheter , urostomy End stage renal disease dialysisdependence Sitting systolic blood pressure upper extremity le 100mm Hg time eligibility screen Presence orthostatic hypotension time eligibility screening ( orthostatic hypotension define drop systolic blood pressure 20mm Hg sit standing , drop diastolic BP 10 mm Hg sit stand 23 minute stand sit position ) Anticipated inability take oral medication postoperative day # 0 Anticipated requirement indwell urinary catheter beyond postoperative day # 2 NonEnglish speaking Pregnant breastfeeding Unwillingness answer 7 question IPSS ( International Prostate Symptom Score ) survey Lacking capacity provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>tamsulosin</keyword>
	<keyword>randomize controlled trial topic</keyword>
	<keyword>double-blind method</keyword>
	<keyword>random allocation</keyword>
	<keyword>placebo</keyword>
	<keyword>Adrenergic alpha-Antagonists</keyword>
	<keyword>urinary retention</keyword>
	<keyword>urinary tract infection</keyword>
	<keyword>urinary catheter</keyword>
	<keyword>catheter-related infection</keyword>
	<keyword>postoperative complication</keyword>
</DOC>